Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

89bio, Inc. · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
associatedsteatoticliverdiseasefattylivermashmasldmetabolicdiseasesmetabolicdysfunction
metabolic dysfunction-associated steatohepatitis (mash) / nonalcoholic steatohepatitis (nash) with compensated cirrhosis, liver disease, fatty liver, digestive system diseases, metabolic diseases, metabolic dysfunction-associated steatohepatitis, mash, nonalcoholic steatohepatitis, nash, metabolic dysfunction-associated steatotic liver disease, masld, nonalcoholic fatty liver disease
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 888266
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.